Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Metabolic Diseases
>>
SGLT
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Suglat
(ipragliflozin) / EMD Serono, Kotobuki, Astellas
Synjardy
(empagliflozin/metformin) / Boehringer Ingelheim, Eli Lilly
Xigduo
(dapagliflozin and metformin extended-release) / AstraZeneca